688314 康拓医疗
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.34113.35914.46321.82923.961
总资产报酬率 ROA (%)2.90911.49312.49418.87620.154
投入资产回报率 ROIC (%)3.10812.37813.49120.37722.012

边际利润分析
销售毛利率 (%)81.21981.18381.47382.62082.902
营业利润率 (%)34.72833.24535.97940.61431.573
息税前利润/营业总收入 (%)33.80032.12235.25544.02134.868
净利润/营业总收入 (%)28.06427.07930.90638.19531.155

收益指标分析
经营活动净收益/利润总额(%)105.135105.57896.51186.65692.773
价值变动净收益/利润总额(%)-9.067-2.0323.9042.2621.705
营业外收支净额/利润总额(%)0.0000.3492.4119.50611.010

偿债能力分析
流动比率 (X)5.4555.3534.6146.1103.789
速动比率 (X)5.0824.9094.1715.4862.828
资产负债率 (%)12.96613.35915.12612.55416.623
带息债务/全部投入资本 (%)5.4265.3746.1453.7324.595
股东权益/带息债务 (%)1,715.7831,729.7301,502.6422,527.0071,989.967
股东权益/负债合计 (%)672.676650.424562.775699.209504.627
利息保障倍数 (X)-36.430-25.925-21.854-51.197-56.997

营运能力分析
应收账款周转天数 (天)9.51012.69011.9228.3708.877
存货周转天数 (天)224.013258.141312.673364.201434.325